InvestorsHub Logo
Followers 14
Posts 708
Boards Moderated 0
Alias Born 08/21/2012

Re: chxal post# 9313

Monday, 03/29/2021 12:21:48 PM

Monday, March 29, 2021 12:21:48 PM

Post# of 14947
News from another stock. Not recommending, just how it’s worded.

CARLSBAD, CA -- March 29, 2021 -- InvestorsHub NewsWire -- OPTEC International, Inc. (OTC Pink: OPTI), a developer of UV and UV-C safety products using related advanced technologies specific to Personal Protection Equipment (PPE), today announced the company is now preparing and stockpiling FDA EUA approved inventory for the launch of the Antigen 10-minute rapid test kits to be made available for use at home & business nationwide.
Due to a recent FDA relaxation of the "emergency use" (EUA) rules applicable for Rapid Test Kit use, most FDA/EUA approved Antigen and Antibody Test Kits will soon be available for purchase by consumers and businesses, both online and over the counter at affordable prices compared to the current Medical facility/Pop-Up medical staff supervised locations with 24–72-hour results.

OPTEC is providing 2 versions of the Nasal CoV-2 Antigen FDA EUA authorized 10-minute rapid test kits. The kits are clinically proven to be reliable and accurate (Clinical evaluation: Positive Percent Agreement (PPA): 88.37% (95% CI: 75.52% – 94.93%), Negative Percent Agreement (NPA): 100% (95% CI: 94.25% – 100%),

The Nasal swab tests detect viral shedding of the RNA of the virus. Using the Antigen Rapid Test Kits provides the ability for all necessary resources to help keep the pandemic at bay for personal family satisfaction, business employee monitoring, schools, senior care centers, medical & dental facilities, government divisions and more.

OPTEC will be offering both versions of the Antigen 10 Minute Nasal Rapid Test Kits: online, via distributors, media channels and bulk PPE networks upon receipt of final approval by FDA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News